Compare ARCT & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCT | MASS |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.9M | 226.6M |
| IPO Year | 2019 | 2020 |
| Metric | ARCT | MASS |
|---|---|---|
| Price | $6.87 | $6.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $27.70 | $12.00 |
| AVG Volume (30 Days) | ★ 460.5K | 256.8K |
| Earning Date | 03-03-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.00 | ★ 125.47 |
| EPS | N/A | ★ 0.54 |
| Revenue | ★ $82,031,000.00 | $56,197,000.00 |
| Revenue This Year | N/A | $19.44 |
| Revenue Next Year | N/A | $18.63 |
| P/E Ratio | ★ N/A | $11.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $3.55 |
| 52 Week High | $24.14 | $9.34 |
| Indicator | ARCT | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 44.30 |
| Support Level | $5.93 | $5.26 |
| Resistance Level | $7.88 | $6.73 |
| Average True Range (ATR) | 0.39 | 0.35 |
| MACD | -0.08 | -0.04 |
| Stochastic Oscillator | 34.93 | 28.81 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.